Oncology

Clinicians Should Be Able to Rely on Coverage for Category 2B Treatments: Eric Lander, MD

NCCN Guideline Updates Help Oncologists Navigate ctDNA Use: Eric Lander, MD

Clinical Trials Financially Beneficial for Patients: Eric Lander, MD

Digitizing NCCN Guidelines Could Improve Enrollment in Clinical Trials: Eric Lander, MD

The Pharmacist’s Role in Value-Based Oncology Models: David Awad, PharmD, BCOP

Introducing New Jersey's Premier NCI-Designated Comprehensive Cancer Care Center: Andrew Evens, DO, MBA, MSc

The Growing Role of AI and Other Technology in Cancer Care: Coral Omene, MD, PhD

Documentation, Collaboration Are Key to Managing Toxicities: David Awad, PharmD, BCOP

Data Collection Helps the Delivery of Equitable Value-Based Cancer Care: Coral Omene, MD, PhD

Potential Impact of Loss of Coverage for Health Care Screenings: Constance Blunt, MD

Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions

Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic

Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman

Oncology Onward: A Conversation With OneOncology’s Dr Jeff Patton

Health Equity Conversations: Improving Diversity of Oncology Care Staff

Lymphoma Research Foundation CEO on Biden’s Cancer Moonshot, Financial Toxicity

Reforming Oncology Care Payments: Interviews From the QCCA Leadership Summit

What Are the Next Steps for Collaboration, Accountability in Oncology Care First?

KOL Corner: Amy Ellis Discusses Value-Based Cancer Rehab With Amanda Hodges

Podcast: This Week in Managed Care—Challenges of Rural Healthcare Delivery and Other Health News